brain Logo
DE
  • 61

    Nature's biodiversity is the source of our innovation: microorganisms and their enzymes open up unique opportunities for us to develop sustainable and scalable solutions for tomorrow's markets.

    • Company
    • Goals & Values
    • Management
      • Products & Services
      • Enzymes, Microorganisms & Ingredients
      • R&D Services
      • Fermentation Services
      • Sites
      • Production, Blending & Distribution
      • R&D Services
      • Markets
      • Life Science & Pharma
      • Food & Beverages
      • Environmental
    • Pipeline
    • Corporate History
    • Contact
  • 131

    We offer innovative biological solutions and products based on microorganisms and enzymes. These enable industry to improve products, make manufacturing processes more efficient and increase the sustainability of products and processes.

    • Investors
      • BRAIN Biotech AG at a Glance
      • Strategy
      • Key financial figures
      • Segments
    • Why invest
      • Corporate Governance
      • Management & Control
      • Executive Management Board
      • Supervisory Board
      • Declaration on corporate governance
      • Statement of conformity 2025
      • Compensation
      • Articles of Association and Rules of Procedure of the Supervisory Board
      • Financial Publications & Calendar
      • Financial and Corporate News
      • Financial Reports
      • Presentations & Videos
      • Financial Calendar
      • Investor Events
      • Capital Markets Day
      • Glossary
    • Share
      • Annual General Meeting
      • Annual General Meeting 2026
      • Archive
    • FAQ
    • Request Information
  • 163

    We follow established national and international guidelines in our strategy for sustainable corporate development and reporting.

    • Sustainability
    • Our Approach
    • ESG-Strategie auf einen Blick
    • Environment
    • Social Responsibility
    • Corporate Management
    • Sustainability Reporting
    • Download Sustainability Report & ESG Fact Sheet
  • 155
    • News & Media
    • News & Stories
    • Press releases
    • Presentations & Videos
    • Press Contact
  • 171
    • Career
    • Working in the BRAIN Biotech Group
    • Apply for sites
    • Job vacancies in the BRAIN Biotech Group
DE
  • Home
  • News & Media
  • Press releases

Press Releases

08.12.2021
Additional Genome Editing Nuclease: BRAIN-Metagenome-Cas 01 (BMC01)
Technology
Show Article
03.11.2021
BRAIN and SAMS apply BEC gene-editing technology to Omega-3 Compounds from Marine Organisms
Technology Corporate
Show Article
15.09.2021
BRAIN Biotech AG successfully placed new share capital for the financing of further growth initiatives
Corporate Finance
Show Article
03.09.2021
Capital Markets Day BRAIN Biotech AG: Focus on BEC Technology and its Transformational Potential
Corporate
Show Article
01.09.2021
BRAIN appoints University of Leiden as partner for BEC-enabled production strain development
Technology
Show Article
30.08.2021
BRAIN Biotech AG 9M ‘20/’21 Results
Finance
Show Article
28.07.2021
Sartorius and BRAIN jointly researching and adapting novel CRISPR Cas-nucleases
Technology Corporate
Show Article
21.07.2021
Novel Genome Editing Tool: Filing of International Patent Application
Technology Corporate
Show Article
08.06.2021
BRAIN actively supports the UN Global Compact
Corporate
Show Article
  • 1
  • 7
  • 8
  • 9
BRAIN Biotech AG

Darmstädter Straße 34 – 36
64673 Zwingenberg
Deutschland

public@brain-biotech.com
Phone: +49 62 51 9331-0
Fax: +49 62 51 9331-11
www.brain-biotech-group.com
Copyright © 2026 BRAIN Biotech AG
Social Networks
Privacy Policy Imprint Contact
Legal aspects Cookie Settings